Ignite Creation Date:
2024-05-06 @ 2:55 AM
Last Modification Date:
2024-10-26 @ 11:25 AM
Study NCT ID:
NCT02152943
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2014-05-29
Brief Title:
Everolimus Letrozole and Trastuzumab in HR- and HER2Neu-positive Patients
Sponsor:
Organization:
MD Anderson Cancer Center